SLC25A20 and hepatocellular carcinoma: Consistent with our finding that SLC25A20 expression is down-regulated and plays anti-tumorigenic functions in HCC, a previous study using whole-genome microarray had also revealed that a series of metabolic enzymes involved in fatty-acid oxidation (FAO) were down-regulated in HCC29.